Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): Prolongation of survival by the combination of interferon α and hydroxyurea
R. Hehlmann, U. Berger, M. Pfirrmann, A. Hochhaus, G. Metzgeroth, O. Maywald, J. Hasford, A. Reiter, D. K. Hossfeld, H. J. Kolb, H. Löffler, H. Pralle, W. Queißer, M. Griesshammer, C. Nerl, R. Kuse, A. Tobler, H. Eimermacher, A. Tichelli, C. AulM. Wilhelm, J. T. Fischer, M. Perker, C. Scheid, M. Schenk, J. Weiß, C. R. Meier, S. Kremers, L. Labedzki, T. Schmeiser, H. P. Lohrmann, H. Heimpel
Resultado de la investigación: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): Prolongation of survival by the combination of interferon α and hydroxyurea'. En conjunto forman una huella única.